Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease

Beta-thalassemia, on the other hand, is a rare disease that affects around 1,000 or so people in the United States. It's more prevalent in some countries but still impacts only one in 100,000 individuals.